This study compares the US response to HIV over the course of the epidemic to that of the following seven other nations: Australia, Canada, France, the Netherlands, Sweden, Switzerland, and the United Kingdom. It focuses mainly on the domestic responses of these eight nations, although their role in addressing the epidemic in developing countries is also examined.
This pamphlet discusses the myths and misconceptions about HIV/AIDS and is part of the Prevention I Cure campaign. Topics include general myths, myths about HIV transmission, HIV therapy, recreational drug use, and other STDs.
This information sheet explains terms, definitions, and methods of calculation used in HIV surveillance data, and the uses of these data. It defines unadjusted data, adjusted (estimated) data, AIDS diagnoses and deaths of persons with an AIDS diagnoses, and diagnoses of HIV infection and deaths of persons with a diagnosis of HIV infection. It also defines HIV incidence, persons living with a diagnosis of HIV infection or AIDS, incidence rate, prevalence rate, stage of disease, and transmission category.
This fact sheet discusses TB and how it is affected by the HIV. It defines TB and explains the difference between TB infection and latent TB infection. The fact sheet advises that HIV weakens the immune system increasing the chance that in people with HIV and latent TB, the TB germs will become active and attack the body causing TB disease. It emphasizes the importance of TB treatment and taking the TB drugs as prescribed.
These guidelines present health care providers with information for discussion with HIV-infected pregnant women to enable the patient/provider team to make informed decisions regarding the use of antiretroviral drugs during pregnancy and use of elective cesarean delivery to reduce perinatal HIV transmission. The recommendations are accompanied by discussion of various circumstances that commonly occur in clinical practice and the factors influencing treatment considerations.
